Switch to:
More From Other Websites
7 Healthcare Dividend Stocks for Quality and Security Aug 26 2016
AbbVie Expects Investigational Drug Elagolix to Be a Blockbuster Aug 26 2016
Could Zinbryta Become a Novel Immunomodulatory Therapy for MS? Aug 26 2016
AbbVie Expects to Launch Zinbryta in the US in August Aug 25 2016
How Late-Stage Asset Rova-T Could Become a Leading Therapy Aug 25 2016
Major Pharma Short Interest Faces Significant Drop Aug 25 2016
How AbbVie Expects BCL-2 Inhibitor Venclexta to Prove Effective Aug 25 2016
Imbruvica Continues to Report Better-than-Expected Sales in 2016 Aug 24 2016
How Humira-Related Uncertainty Has Affected AbbVie’s Valuations Aug 24 2016
AbbVie Expects to Commercialize Selective JAK1 Inhibitor ABT-494 Aug 24 2016
How AbbVie Expects Risankizumab to Be a Transformative Therapy Aug 23 2016
What Are Analysts’ Recommendations for AbbVie in 2016? Aug 23 2016
How AbbVie’s Valuation Multiples Compare with Its Peers’ Aug 23 2016
[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
Can Allergan Generics Boost Teva Pharmaceutical’s 2016 Revenues? Aug 22 2016
Zacks Value Investor Highlights: AbbVie, Berry Plastics, Hawaiian Holdings, Toll Brothers and Pulte Aug 19 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK